Discovery of 3,3′-diindolylmethanes as potent antileishmanial agents
- 1 May 2013
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 63, 435-443
Abstract
No abstract availableKeywords
Funding Information
- US Department of Defense CDMRP (#W81XWH-09)
- NIH, NIAID, Division of AIDS (AI27094)
This publication has 53 references indexed in Scilit:
- The treatment of visceral leishmaniasis (kala-azar) in India: no obvious signs of long-term successTransactions of the Royal Society of Tropical Medicine and Hygiene, 2012
- Antiprotozoal and Antimicrobial Compounds from the Plant Pathogen Septoria pistaciarumJournal of Natural Products, 2012
- In Vitro Potency and In Vivo Efficacy of a Novel Bis-Indole Antimicrobial Compound in Reducing Catheter ColonizationAntimicrobial Agents and Chemotherapy, 2012
- Immunobiology of visceral leishmaniasisFrontiers in Immunology, 2012
- Design and synthesis of novel N,N′-glycoside derivatives of 3,3′-diindolylmethanes as potential antiproliferative agentsMedChemComm, 2012
- Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trialBritish Journal of Cancer, 2011
- Inactivation of the Orphan Nuclear Receptor TR3/Nur77 Inhibits Pancreatic Cancer Cell and Tumor GrowthCancer Research, 2010
- Novel 3,3′-diindolylmethane derivatives: Synthesis and cytotoxicity, structural characterization in solid stateEuropean Journal of Medicinal Chemistry, 2009
- Alkaloids: Future prospective to combat leishmaniasisFitoterapia, 2009
- Bulk and supported tungstophosphoric acid as friendly, efficient, recyclable catalysts for the synthesis of bis-indolylmethanes under solvent-free conditionsHeteroatom Chemistry, 2009